MALVERN, PA -- (Marketwire) -- 02/04/10 -- Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year...

(NASDAQ:AUXL - News), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the...

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the financial...

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the...

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the...

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the financial...

About Auxilium Auxilium Pharmaceuticals, Inc.

is a specialty biopharmaceutical company with a focus on developing and marketing to urologists, endocrinologists,...

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday,...

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the financial markets.

The Company will also conduct a...

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the financial markets.

The Company will also conduct a...

(NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter and full year 2009 on Wednesday, February 17, 2010 before the opening of the financial markets.

The Company will also conduct a...

(NASDAQ: CPEX) today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rof, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of...

(NASDAQ: CPEX) today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rof, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of...

CPEX today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rof, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of Mr.

Rof...

- (Business Wire) CPEX Pharmaceuticals, Inc.

(NASDAQ: CPEX) today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rof, who hold approximately 12% of...

(NASDAQ: CPEX - News) today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rof, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange...

CPEX stated that no offer has been made and that shareholders do not need to take any...

(NASDAQ: AUXL) today announced that executive management will participate in the 28th Annual J.P.

Morgan Healthcare Conference to be held January 11 - 14, 2010 at Westin St.

Francis Hotel in San Francisco.

Armando Anido,...

(NASDAQ: AUXL) today announced that executive management will participate in the 28th Annual J.P.

Morgan Healthcare Conference to be held January 11 - 14, 2010 at Westin St.

Francis Hotel in San Francisco.

Armando Anido,...

(NASDAQ: AUXL) will present at the 28th Annual JP Morgan Healthcare Conference.

The conference is being held in San Francisco, California, at the Westin St.

(NASDAQ: AUXL) today announced that executive management will participate in the 28th Annual J.P.

Morgan Healthcare Conference to be held January 11 - 14, 2010 at Westin St.

Francis...

The replay will be available for ninety days after the event.

About Auxilium Auxilium Pharmaceuticals, Inc.

is a specialty...

- Financial and Strategic Analysis Review, provides detailed company analysis Published on December 09, 2009by Press Office(Companiesandmarkets.com and OfficialWire)LONDON, ENGLAND Auxilium Pharmaceuticals...

- Pharmaceuticals & Healthcare - Deals and Alliances Profile, provides detailed company analysis Published on November 25, 2009by Press Office(Companiesandmarkets.com and OfficialWire)LONDON, ENGLAND...